This is a pragmatic, multi-center, prospective, observational, non-interventional study and standing database of patients seen at the training institution for cognitive impairment diagnosed with Mild Cognitive Impairment (MCI) or Dementia. All patients seen at the training institution clinically diagnosed with MCI or dementia by their neurologists will be invited to participate in the study. The investigators will confirm the diagnosis and will explain the study as well as the patient information sheet to the patient and/or legal representative. All eligible patients seen will be assigned a study identification number. Data will be collected by the investigators as the patient undergoes routine clinical evaluation. Corresponding anonymized data on demographics, medical history and risk factors, level of functional impairment, diagnosis, baseline cognitive scores and management will be collected from each patient and entered in the database using a secure online data collection tool.
The investigators will confirm the diagnosis and will explain the study as well as the patient information sheet to the patient and/or legal representative. All eligible patients seen will be assigned a study identification number. Data will be collected by the investigators as the patient undergoes routine clinical evaluation. Corresponding anonymized data on demographics, medical history and risk factors, level of functional impairment, diagnosis, baseline cognitive scores and management will be collected from each patient and entered in the database using a secure online data collection tool. Patients who withdraw participation verbally or in writing are excluded by the investigator from further participation. Withdrawal from the study will be properly documented, including date, time, and reason for withdrawal. Withdrawn subjects will not have their clinical data included in the database. Collective data will be extracted, summarized, and analyzed every year with oversight provided by the Philippine Neurological Association (PNA). To be able to assess trends and changes over time, data collection for this study will span 3 years from study initiation, after which the utility of an extension or a re-implementation of the study will be assessed by the PNA.
Study Type
OBSERVATIONAL
Enrollment
73
The clinical diagnosis will be made based on the criteria set by the investigators. Clinical history and bedside objective assessment in the form of Montreal Cognitive Assessment-Philippines (MoCA-P) or Mini Mental Status Examination-Philippines (MMSE-P), supported by a neuroimaging study (if neuroimaging is not done, diagnosis will be supported by the Hachinski Ischemic Score).
Baguio General Hospital and Medical Center
Baguio City, Baguio, Philippines
RECRUITINGChong Hua Hospital
Cebu City, Cebu, Philippines
RECRUITINGMakati Medical Center
Makati City, National Capital Region, Philippines
RECRUITINGThe Medical City
Pasig, National Capital Region, Philippines
NOT_YET_RECRUITINGEast Avenue Medical Center
Quezon City, National Capital Region, Philippines
RECRUITINGQuirino Memorial Medical Center
Quezon City, National Capital Region, Philippines
RECRUITINGSt. Luke's Medical Center
Quezon City, National Capital Region, Philippines
NOT_YET_RECRUITINGJose R. Reyes Memorial Medical Center
Manila, Philippines
RECRUITINGUniversity of Santo Tomas Hospiatl
Manila, Philippines
RECRUITINGUniversity of the East- Ramon Magsaysay Memorial Medical Center
Manila, Philippines
RECRUITING...and 1 more locations
Frequency of dementia and mild cognitive impairment in the study population
To determine the frequency of dementia and mild cognitive impairment in the study
Time frame: on Day 1
F frequency of the different types of dementia in the study population
To determine the frequency of the different types of dementia in the study population using the clinical diagnosis
Time frame: on Day 1
Frequency of risk factors for dementia in the study population
o determine the frequency of risk factors for dementia in the study population. (age, sex, educational attainment, family history, physical activity, smoking history, alcohol consumption, cardiovascular and cerebrovascular risk factors, chemical exposure, substance abuse, previous psychiatric condition and hearing impairment)
Time frame: on Day 1
Demographic characteristics of patients with dementia or mild cognitive impairment
To describe the demographic characteristics of patients with dementia or mild cognitive impairment as to age at the time of diagnosis, age of onset of symptoms, sex, level of income (of patient or caregiver), location of clinic or hospital, current or previous occupation, educational attainment, neurologic exam findings
Time frame: on Day 1
Dementia Severity
To categorize dementia severity in each subtype as mild, moderate and severe based on the initial MMSE score at the time of diagnosis.
Time frame: on Day 1
Diagnostic tests used at the time of the diagnosis
To describe the types of diagnostic tests commonly done at the time of diagnosis, such as neuroimaging, blood tests, EEG
Time frame: on Day 1
Pharmacologic and nonpharmacologic modalities used
To identify pharmacologic and nonpharmacologic modalities of treatment currently being used in the treatment of dementia
Time frame: on Day 1
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.